If an HIV prevention pill that provides a month of protection at a time performs well in two ongoing clinical trials, it could become the next big thing in HIV prevention after the lenacapavir injection. A new licensing agreement is paving the way for South Africa’s Aspen Pharmacare to produce the pill should the study…
Rio de Janeiro, Brazil — The global fight against HIV has never had more powerful scientific tools or faced greater political uncertainty. More than 7,000 scientists, activists, policymakers and community leaders gathered in Rio de Janeiro for the opening of the International AIDS Conference. Global leaders warned that decades of progress against the epidemic could be…
Rio de Janeiro, Brazil — For two decades, donor funding helped build one of the world’s most successful HIV responses. Now, as the United States scales back support, legal scholar Mnotho Ngcobo says Africa is confronting not just a funding crisis, but a constitutional and ethical one. Ngcobo, an assistant professor of law at the…
Accra — PRESIDENT’S Advisor on Reproductive, Maternal and Child Health, Ummy Mwalimu, has participated in a special African Union (AU) Heads of State and Government Summit in Accra, Ghana, focused on accelerating efforts to end AIDS by 2030 and strengthen health systems across Africa. The meeting reviewed strategies to eliminate HIV/AIDS, reduce preventable maternal deaths,…
Brazil has hosted clinical trials paving the way for lenacapavir’s approval and sale, but the medicine remains widely inaccessible for people there. As the 26th International AIDS Conference kicks off this weekend in Rio de Janeiro, Brazil, Doctors Without Borders/Médecins Sans Frontières (MSF) continues to urge the US pharmaceutical corporation Gilead Sciences to make the…
HEADS of State and Government, health ministers and experts, policy makers and development partners have met in Accra with a resolve to advance the continent’s health agenda, focusing on ending AIDS and tuberculosis by 2030, reducing maternal mortality, and boosting local pharmaceutical manufacturing. Among the attendees were Presidents John Dramani Mahama, Ghana; Évariste Ndayishimiye, Burundi;…
For over four decades, the global AIDS response has been powered by grief, rage, courage, and determination. Families buried loved ones long before their time. Communities confronted discrimination and built networks of care when the silence was deafening. Scientific breakthroughs and community-driven innovation transformed HIV from a near-certain death sentence into a chronic, manageable condition….
France cut its contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria by 58 percent on Thursday, confirming a major reduction in funding that health organisations warn will cost lives. After months of uncertainty, the government said its pledge for the 2026-2028 cycle will fall from €1.6 billion in the previous funding period…
The decision by the United States government to retreat from public recognition of World AIDS Day, and to withhold the release of its annual HIV data, is being treated globally as a political earthquake. But World AIDS Day was not created in a US government office and it does not depend on a White House…
South Africa, Eswatini and Zambia were to begin on Monday administering a groundbreaking new HIV-prevention injection in the drug’s first public rollouts in Africa, which has the world’s highest HIV burden. Lenacapavir, taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, making it functionally akin…
